Page 3844 - Week 11 - Tuesday, 19 September 2017
Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video
and the implementation of clearly defined quality assurance and clearance steps for all data reporting and analysis.
In addition, work schedules and steps for key reporting obligations have been defined. The activities of pillar 3, phase 1 covered reporting obligations. The works undertaken in this pillar included the identification and consolidation of the vast quantum of reports produced across the directorate. I am pleased to advise that a thorough process has been followed to identify and capture all internal and external reporting obligations. As a result, a range of essential internal and external reports have been identified, based on their classification as funding, legislative and/or reputation.
Milestone 1 activities identified the interim processes required to generate 69 essential and priority external reports and 16 essential and priority internal reports, with a new scorecard for clinical areas with a range of metrics such as financial, activity, quality and safety, accountability and budget indicators, and a subset relevant to each division.
The review panel also wants to ensure that historical approaches of isolated work practices are addressed, and this continues as clinicians and corporate partners are engaged and educated. I am pleased to advise that work continues unabated on these activities as we approach the due date for milestone 2 of 30 September 2017.
Madam Speaker, providing assurances for ACT Health data collection, analysis and reporting is a complex matter, which is why the Canberra Hospital executive receives a range of monthly benchmark reports that summarise key performance metrics to enable them to accurately manage their clinical services. These reports are being reviewed to ensure that clinicians have the critical information necessary to run their areas.
ACT Health is prioritising and undertaking essential data reporting covering key performance metrics and activity data to a range of government bodies, including the Australian Bureau of Statistics, the Australian Institute of Health and Welfare, the Independent Hospital Pricing Authority, the National Health Funding Body and the Productivity Commission. This includes submissions to a range of agencies, such as the Independent Hospital Pricing Authority and the National Health Funding Body.
Of course, the community and other stakeholders also have an interest in ACT Health data to understand the performance and quality of our health system. I have asked Health and the review panel to consider the provision of information for these purposes. They have advised me that ACT Health are very confident of providing the full range of 2016-17 reporting metrics in the ACT Health annual report, to be tabled in the Legislative Assembly next month. Following the tabling of the annual report, the review panel has advised that reports outside the essential reports should be considered individually, given the core focus on the system-wide review development activities. Following the tabling of the 2016-17 annual report, the review panel will continue to advise on the progress of authenticating data for reporting purposes, pending the finalisation of the review in March 2018.
Madam Speaker, I am pleased to advise members that ACT Health is also continuing to engage in ongoing communication with key stakeholders, to keep them informed of
Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Debates(HTML) . . . . PDF . . . . Video